Complement component 1s

Complement component 1s (C1s) is a protein enzyme that plays a crucial role in the complement system, which is an essential part of the innate immune system. The complement system helps to clear pathogens from an organism. C1s is part of the C1 complex, which also includes C1q and C1r, and is involved in the classical pathway of complement activation.

Structure and Function

C1s is a serine protease that, once activated, is responsible for cleaving and activating the next components in the pathway, C4 and C2, to form the C3 convertase, C4b2a. This enzyme complex then cleaves C3, marking pathogens for destruction and initiating a series of immune responses including opsonization, inflammation, and cell lysis.

The activation of C1s is tightly regulated. It is initially part of the C1 complex, which is bound to C1q. The activation occurs when C1q binds to the Fc region of IgG or IgM that is bound to antigens on the surface of a pathogen. This binding causes a conformational change in C1q, which activates C1r. C1r then cleaves and activates C1s.

Genetic and Molecular Aspects

The gene encoding C1s is located on chromosome 12 in humans. Mutations in this gene can lead to deficiencies in the complement system, which can result in increased susceptibility to infections and autoimmune diseases. The molecular weight of the C1s protein is approximately 85 kDa.

Clinical Significance

Deficiencies in C1s are rare but can lead to a range of immune disorders. For example, a deficiency in C1s can result in a form of systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Additionally, because the complement system plays a role in inflammation, dysregulation of C1s activity can contribute to inflammatory diseases.

Inhibitors of C1s are being explored as potential therapeutic agents for diseases involving excessive complement activation, such as hereditary angioedema, a condition characterized by sudden and severe swelling of the skin and mucous membranes.

Research Directions

Research on C1s is focused on understanding its structure-function relationships, regulation of its activity, and its role in disease. Studies on C1s inhibitors for therapeutic purposes are also a significant area of interest, particularly for conditions where the complement system's activation contributes to disease pathology.

See Also

• Complement system
• Innate immune system
• Serine protease
• Hereditary angioedema

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian